On December 11th 2017, I, like everyone who lives with or cares about Huntington’s Disease, woke up to the headline news, that American company IONIS had completed phase one clinical trials that demonstrated their experimental drug IONIS-Httrx (now called the equally inspiring name of Roche 6042) had lowered the levels
Discussion
What would you like to hear about?
Part of the aim of HeaDline is to create a space for discussion about the development of HD treatments. I’d love to hear from you about what matters to you about this subject and I’ll do my best to answer or find out ! Let me know your thoughts!
Ask the expert: Q&A
Ask the expert: Q&A on Huntingtin-Lowering trial Program A Q&A with Dr. Ed Wild hosted by HDBuzz. After receiving a large number of questions from the community, Dr. Ed Wild answers them in his role as the Co-Founder of HDBuzz and as Scientific Adviser to the Huntington’s Disease Association (HDA).